Trade AstraZeneca ^AZN

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 34% One Year Rally?

Astrazeneca (NYSE:AZN) Earns Buy Rating from JPMorgan Chase & Co. - Daily Political

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Breast Cancer Treatment from Daiichi Sankyo, AstraZeneca Approved in U.S. | Morningstar

Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer | Morningstar

AstraZeneca (AZN) Sees Leadership Changes at FDA

Bristol Myers Squibb turns to China's Hengrui to replenish pipeline

ULTOMIRIS Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Expert recommendations for PIK3CA testing in HR+/HER2− locally advanced and metastatic breast cancer

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

'Pfizer and AstraZeneca were ABANDONED, yet…': Sen Johnson drops bombshell on COVID vaccine injuries - The Economic Times Video | ET Tv

AZN Shows Promising Results in Phase III Trial for Muscle-Invasive Bladder Cancer

AZN: Promising Phase III Trial Results for Imfinzi in Bladder Cancer Treatment

AstraZeneca's Imfinzi Shows Promising Survival Benefits in Bladder Cancer Trial, ETPharma

JPMorgan Chase & Co. Reiterates Buy Rating for Astrazeneca (NYSE:AZN) - Stock Observer

AstraZeneca Says Imfinzi Combination Improved Survival In Phase III Bladder Cancer Trial

Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ...

AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41

Health: AstraZeneca's Imfinzi with pre-surgery drug boosts survival in bladder cancer trial

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Innate Pharma présente l'avancée de son portefeuille et ses résultats financiers du premier trimestre 2026

In the clinic for May 13, 2026 | BioWorld

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial

Implementing AI in workflows: One step at a time

UK junior minister Miatta Fahnbulleh resigns, urges PM Starmer to set exit timetable

AstraZeneca PLC (LON:AZN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political

AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study

PRIMECAP Management's Strategic Moves: AstraZeneca PLC Exits with a -2.57% Impact

Cellectis Reports Financial Results for the First Quarter 2026

Cellectis publie ses résultats financiers du premier trimestre 2026

CDT Equity Advances AstraZeneca PLC (AZN)'s AZD5904 Into PCT Patent Protection Stage

Drug companies involved in TrumpRx boosted lobbying by 23% ahead of program's launch

Astrazeneca Plc $AZN Position Boosted by NewEdge Wealth LLC

Mitsubishi UFJ Asset Management Co. Ltd. Raises Holdings in Astrazeneca Plc $AZN - Stock Observer

Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancer

5 Best Cancer Stocks to Buy for the Long Term

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

Genmab A/S (0MGB) Receives a Buy from Goldman Sachs

Denali Advisors LLC Raises Stock Position in Astrazeneca Plc $AZN - Zolmax

Channel Wealth LLC Sells 10,555 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Stake Boosted by Ethic Inc. - Daily Political

Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response

/DISREGARD RELEASE: Pactum/ | Morningstar

Darren Sissons' Past Picks: AstraZeneca, Canadian Pacific Kansas City & Linde Plc - BNN Bloomberg

Astrazeneca FY2026 EPS Estimate Lowered by Erste Group Bank - Stock Observer

14,706 Shares in Astrazeneca Plc $AZN Acquired by RFG Advisory LLC - Stock Observer

AZN's AZD5904 Advances to Patent Cooperation Treaty Stage

Astrazeneca Plc $AZN Shares Purchased by MGO One Seven LLC - Daily Political

From R&D to M&A: Big Pharmas showcase 'measurable impact' of AI

Pactum To Showcase Agentic AI Procurement Solutions On Stage with AstraZeneca at Coupa Inspire 2026 | Morningstar

AstraZeneca PLC (LON:AZN) Given Average Recommendation of "Moderate Buy" by Brokerages

Principal Financial Group Inc. Reduces Holdings in Astrazeneca Plc $AZN - Stock Observer

Newcomer anti-IL-33 makes strides in COPD

Ken Fisher's Strategic Moves: AstraZeneca PLC Leads the Portfolio Additions

6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash

Providence First Trust Co Takes $648,000 Position in Astrazeneca Plc $AZN

Indivisible Partners Acquires New Shares in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca (LON:AZN) Given Sell Rating at Deutsche Bank Aktiengesellschaft - Daily Political

Manufacturing Stocks To Research - May 5th - Zolmax

Manufacturing Stocks To Research - May 5th - Daily Political

M&T Bank Corp Decreases Stock Holdings in Astrazeneca Plc $AZN - Zolmax

Benjamin Edwards Inc. Trims Stake in Astrazeneca Plc $AZN

Wealthfront Advisers LLC Invests $422,000 in Astrazeneca Plc $AZN - Daily Political

Sigma Planning Corp Buys 5,917 Shares of Astrazeneca Plc $AZN - Daily Political

The transformative role of SBRT in the management of spinal metastases

Strong Results and Improved Guidance Lifted AstraZeneca PLC (AZN)

Mixed FDA Votes On Truqap And Camizestrant Refocus AstraZeneca Oncology Risk

Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its Strong Five Year Run?

With £9,633.30 to invest, are these the best UK stocks to buy now?

US Bancorp DE Acquires 16,922 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by D.A. Davidson & CO.

Wall Street Zen Upgrades Astrazeneca (NYSE:AZN) to Buy

A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Pullback

Manufacturing Stocks To Consider - April 30th - Stock Observer

AstraZeneca Faces Setback as FDA Advisory Panel Rejects Cancer Drug (AZN)

UK's FTSE 100 Closes Lower; NatWest, AstraZeneca Shares Down

Top Manufacturing Stocks To Watch Now - May 1st - Daily Political

Futures Rise, Oil Slides On Iran Ceasefire Optimism After Best Month For Stocks Since 2020

FTSE 100 drops in thin trading as NatWest, AstraZeneca weigh

JPY breaches Thursday low in potential further intervention, bourses in thin trade amid holiday, US futures lacklustre - US Market Open

Astrazeneca (NYSE:AZN) Upgraded to Buy at Barclays - Daily Political

Astrazeneca (NYSE:AZN) Given "Sell" Rating at Deutsche Bank Aktiengesellschaft - Daily Political

Head-To-Head Contrast: AstraZeneca (OTCMKTS:AZNCF) vs. Otsuka (OTCMKTS:OTSKY) - Stock Observer

TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk